Dr Sarah Birkhoelzer reports from the ESC Heart Failure Congress in Barcelona, sharing some insights from the fascinating not-to-be-missed sessions.
Dr Sharon Chadwick discusses these challenging issues and more, explaining how the end-of-life care for heart failure patients can and should be improved. She explores how palliative care doesn't necessarily mean the end of living well for patients with heart failure.
GPs Neil Paul and Martin Godfrey discuss the functions and roles of artificial intelligence (AI) and how digital healthcare may revolutionise and improve future general practice. In this fascinating and hugely relevant conversation, the doctors explore how AI can support clinicians in contemporary primary care for cardiovascular health.
The increasing toxicity profile of cancer treatments has resulted in a growing demand for specialist cardio-oncology care. Listen to Dr SivaTharshini Ramalingam discuss how hospitals and community practitioners can work together to identify, treat and improve the quality of life for people experiencing cardiac dysfunction as a consequence of cancer treatments. She also explains which drugs are most commonly used, their key toxicities and reg flags for care.
This Masterclass was developed in collaboration with the National Amyloidosis Centre, London UK
Amyloidosis is rapidly gaining recognition as a previously under-diagnosed cause of cardiomyopathy and heart failure. Here, experts from the National Amyloidosis Centre – the only centre in the UK specialising in the management of the condition – provide an overview of its prevalence, symptoms and key treatment principles.
Amyloidosis is rapidly gaining recognition as a previously under-diagnosed cause of cardiomyopathy and heart failure. Here, experts from the National Amyloidosis Centre – the only centre in the UK specialising in the management of the condition – provide an overview of its prevalence, symptoms and key treatment principles.
Masterclass
